0001235802-22-000024.txt : 20220202 0001235802-22-000024.hdr.sgml : 20220202 20220202164527 ACCESSION NUMBER: 0001235802-22-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cundari Dominic R CENTRAL INDEX KEY: 0001907057 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36291 FILM NUMBER: 22584327 MAIL ADDRESS: STREET 1: TWO CARLSON PARKWAY, SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc. CENTRAL INDEX KEY: 0001401040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 BUSINESS PHONE: (763) 496-5454 MAIL ADDRESS: STREET 1: TWO CARLSON PARKWAY STREET 2: SUITE 260 CITY: MINNEAPOLIS STATE: MN ZIP: 55447 FORMER COMPANY: FORMER CONFORMED NAME: DiaMedica Inc. DATE OF NAME CHANGE: 20070525 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2022-02-01 0 0001401040 DiaMedica Therapeutics Inc. DMAC 0001907057 Cundari Dominic R TWO CARLSON PARKWAY, SUITE 260 MINNEAPOLIS MN 55447 0 1 0 0 Chief Commercial Officer Voting Common Shares, no par value per share 2800 D Stock Option (right to buy) 2.9 2022-02-01 4 A 0 125000 0 A 2032-02-01 Common Shares 125000 125000 D Stock Option (right to buy) 2.9 2022-02-01 4 A 0 40000 0 A 2032-02-01 Common Shares 40000 40000 D This option vests with respect to 31,250 common shares on February 1, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date. This option vests with respect to 10,000 common shares on May 1, 2022 and with respect to the remaining 75% of the common shares in three nearly equal installments on each of August 1, 2022, November 1, 2022 and February 1, 2023. /s/ Amy Culbert, attorney-in-fact 2022-02-02